Literature DB >> 20404153

Interleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2A.

JiHoon Chang1, Timothy J Voorhees, Yusen Liu, Yongge Zhao, Cheong-Hee Chang.   

Abstract

IL-12 and IL-23 are produced by activated antigen-presenting cells but the two induce distinct immune responses by promoting Th1 and Th17 cell differentiation, respectively. IL-23 is a heterodimeric cytokine consisting of two subunits: p40 that is shared with IL-12 and p19 unique to IL-23. In this study, we showed that the production of IL-23 but not IL-12 was negatively regulated by protein phosphatase 2A (PP2A) in dendritic cells (DC). PP2A inhibits IL-23 production by suppressing the expression of the IL-23p19 gene. Treating DC with okadaic acid that inhibits the PP2A activity or knocking down the catalytic subunit of PP2A with siRNA enhanced IL-23 but not IL-12 production. Unlike PP2A, MAP kinase phosphatase-1 or CYLD did not show an effect on IL-23 production supporting the specificity of PP2A. PP2A-mediated inhibition requires a newly made protein that is likely responsible for bringing PP2A and IKKbeta together upon LPS stimulation, which then results in the termination of IKK phosphorylation. Thus, our results uncovered an important role of the protein phosphatase in the regulation of IL-23 production and identified PP2A as a previously uncharacterized inhibitor of IL-23p19 expression in DC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404153      PMCID: PMC2889593          DOI: 10.1073/pnas.0914703107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activity.

Authors:  Shashi Prajapati; Udit Verma; Yumi Yamamoto; Youn Tae Kwak; Richard B Gaynor
Journal:  J Biol Chem       Date:  2003-10-29       Impact factor: 5.157

2.  Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells.

Authors:  Jihoon Chang; Steven L Kunkel; Cheong-Hee Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

3.  A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.

Authors:  J A DiDonato; M Hayakawa; D M Rothwarf; E Zandi; M Karin
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

4.  Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics.

Authors:  C Bialojan; A Takai
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

5.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors:  B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

Review 6.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

7.  Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development.

Authors:  Hermelijn H Smits; Astrid J van Beelen; Christina Hessle; Robert Westland; Esther de Jong; Eelco Soeteman; Agnes Wold; Eddy A Wierenga; Martien L Kapsenberg
Journal:  Eur J Immunol       Date:  2004-05       Impact factor: 5.532

8.  Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells.

Authors:  Amir F Sheibanie; Iman Tadmori; Huie Jing; Evros Vassiliou; Doina Ganea
Journal:  FASEB J       Date:  2004-06-04       Impact factor: 5.191

9.  An inactive protein phosphatase 2A population is associated with methylesterase and can be re-activated by the phosphotyrosyl phosphatase activator.

Authors:  Sari Longin; Jan Jordens; Ellen Martens; Ilse Stevens; Veerle Janssens; Evelien Rondelez; Ivo De Baere; Rita Derua; Etienne Waelkens; Jozef Goris; Christine Van Hoof
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

10.  Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.

Authors:  Edmund Lee; William L Trepicchio; Judith L Oestreicher; Debra Pittman; Frank Wang; Francesca Chamian; Madhav Dhodapkar; James G Krueger
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

View more
  18 in total

Review 1.  Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer.

Authors:  Juming Yan; Mark J Smyth; Michele W L Teng
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

2.  Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.

Authors:  Jui-Hung Yen; Weimin Kong; Kirsten M Hooper; Frances Emig; Kate M Rahbari; Ping-Chang Kuo; Barbara A Scofield; Doina Ganea
Journal:  J Leukoc Biol       Date:  2015-06-09       Impact factor: 4.962

3.  Cytomegalovirus Infection Exacerbates Experimental Colitis by Promoting IL-23 Production.

Authors:  Lingling Xuan; Lulu Ren; Feifei Han; Lili Gong; Zirui Wan; Song Yang; He Liu; Yali Lv; Lihong Liu
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

4.  IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.

Authors:  Allison E Reeme; Halli E Miller; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2013-03-13       Impact factor: 3.131

5.  Pro-inflammatory effects of palytoxin: an in vitro study on human keratinocytes and inflammatory cells.

Authors:  Marco Pelin; Chiara Florio; Cristina Ponti; Marianna Lucafò; Davide Gibellini; Aurelia Tubaro; Silvio Sosa
Journal:  Toxicol Res (Camb)       Date:  2016-05-17       Impact factor: 3.524

6.  Kynurenic acid downregulates IL-17/1L-23 axis in vitro.

Authors:  Sanam Salimi Elizei; Malihe-Sadat Poormasjedi-Meibod; Xia Wang; Maryam Kheirandish; Aziz Ghahary
Journal:  Mol Cell Biochem       Date:  2017-03-11       Impact factor: 3.396

7.  STAT4 activation by leukemia inhibitory factor confers a therapeutic effect on intestinal inflammation.

Authors:  Yanan S Zhang; Dazhuan E Xin; Zhizhang Wang; Xinyang Song; Yanyun Sun; Quanli C Zou; Jichen Yue; Chenxi Zhang; Junxun M Zhang; Zhi Liu; Xiaoren Zhang; Ting C Zhao; Bing Su; Y Eugene Chin
Journal:  EMBO J       Date:  2019-02-15       Impact factor: 11.598

Review 8.  Interleukin-23: as a drug target for autoimmune inflammatory diseases.

Authors:  Chunlei Tang; Shu Chen; Hai Qian; Wenlong Huang
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

9.  Novel approach for interleukin-23 up-regulation in human dendritic cells and the impact on T helper type 17 generation.

Authors:  Qunwei Wang; Hester A Franks; Joanne Porte; Mohamed El Refaee; Suharsh Shah; James Crooks; Poulam M Patel; Andrew M Jackson
Journal:  Immunology       Date:  2011-06-30       Impact factor: 7.397

10.  MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity.

Authors:  Thomas X Lu; Jochen Hartner; Eun-Jin Lim; Victoria Fabry; Melissa K Mingler; Eric T Cole; Stuart H Orkin; Bruce J Aronow; Marc E Rothenberg
Journal:  J Immunol       Date:  2011-08-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.